RXO (RXO) Is Up 9.9% After Revenue Rises But Losses Persist Is The Thesis Shifting?

• RXO, Inc. reported past second-quarter 2026 results, with sales rising to US$1,774 million from US$1,419 million a year earlier while net loss held at US$9 million, and first-half sales increasing to US$3,199 million from US$2,852 million as net loss widened slightly to US$45 million.
• The combination of stronger revenue volumes and unchanged quarterly loss suggests RXO converted higher demand into sales but has yet to translate that into improved profitability.
• With revenue growing but losses persisting, we’ll now examine how this earnings update affects RXO’s investment narrative and risk profile.

Invest in the nuclear renaissance through our list of 92 elite nuclear energy infrastructure plays powering the global AI revolution.

RXO Investment Narrative Recap

To own RXO today, you need to believe its tech focused, asset light freight brokerage can turn rising revenue into consistent profits while weathering a still soft freight backdrop. The latest quarter showed higher sales but ongoing losses, so the key short term catalyst remains clearer progress on margin improvement, while the biggest risk is that elevated costs and a weak pricing environment keep the business stuck at or near break even; this update does not materially change that balance.

In that context, RXO’s upcoming presentation at Deutsche Bank’s Chicago Industrials Summit is worth watching, as it gives management a platform to explain how recent product launches in middle mile and the RXO Extra marketplace, together with new security partnerships, might support better load mix and operational efficiency. For investors, any concrete detail on how these initiatives link to improving unit economics and reducing loss per share will be especially important.

Yet despite growing revenue and a strong tech story, investors should be aware that RXO still faces meaningful pressure from rising costs and an uncertain freight cycle...

Read the full narrative on RXO (it's free!)

RXO's narrative projects $8.0 billion revenue and $188.3 million earnings by 2029.

Uncover how RXO's forecasts yield a $24.47 fair value, a 4% upside to its current price.

Exploring Other Perspectives

The most pessimistic analysts were assuming only about 7.7 percent annual revenue growth to roughly US$7.2 billion and modest 0.7 percent margins, so this stronger sales print may either ease those concerns about technology driven margin pressure or reinforce worries that higher volumes are not improving profits, reminding you that reasonable people can interpret the same RXO results in very different ways.

Explore 4 other fair value estimates on RXO - why the stock might be worth 14% less than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your RXO research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free RXO research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate RXO's overall financial health at a glance.

Seeking Other Investments?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• Rare earth metals are the new gold rush. Find out which 28 stocks are leading the charge.
• Outshine the giants: these 17 early-stage AI stocks could fund your retirement.
• Explore 24 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com